CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TCI Gene Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TCI Gene Inc
10F-1
No.185, Gangqian Road, Neihu District
Phone: +886 226581218p:+886 226581218 TAIPEI, 114  Taiwan Ticker: 68796879
Business Summary
TCI Gene Inc is a Taiwan-based company mainly engaged in the provision of genetic testing services. The main products include genetic testing services, virus testing services, cell experiment services, production of adipose-derived stem cell preparations for the treatment of degenerative arthritis and knee cartilage defects, production of natural killer cell preparations for the treatment of solid cancer, and personalized genetic health food. Genetic testing technology is mainly in the field of disease risk and drug genetic testing, including comprehensive genetic testing, child growth and development genetic testing, youth beauty genetic testing, weight management genetic testing, anti-aging genetic testing, cardiovascular drug genetic testing and depression/insomnia Pharmacogenetic testing. The Company's products are mainly sold in Taiwan.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8071 Medical laboratories
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Yung-HsiangLin 3/23/2022 5/17/2012
General Manager, Director Chen-ChenFu 3/23/2022 6/30/2021
Head of Accounting JunweiLin 7/25/2023 7/25/2023
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 26,459,000 (As of 12/31/2023)
Shareholders: 129
Stock Exchange: TPO
Fax Number: +886 226587686


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024